Redeye initiates coverage of Cellavision

Redeye initiates coverage of Cellavision We initiate coverage of CellaVision, the undisputed market leader in digital microscopy for hematology. While the share gives investors exposure to an important long-term technology shift and the company has performed impressively, we see limited short-term upside potential in the share at current levels. However, we see long-term potential in the case and believe that short-term dips can provide good opportunities to buy the share. Read more and download the research update: http://bit.ly/379KGre Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/ ------------------------------------------------------------ Denna information skickades av Cision http://news.cision.com/se https://news.cision.com/se/cellavision/r/redeye-initiates-coverage-of-cellavision,c3032284